Exhaled oxidative stress biomarkers and its response to antibiotic treatment in cystic fibrosis (CF)
F. Cardinale, M. Corradi, R. Tesse, A. Manca, F. De Robertis, T. Tronci, A. Dellino, M. Berardi, M. F. Mastrototaro, M. S. Loffredo, F. Mangini, F. Cristofori, F. Di Domenico, L. Armenio (Bari, Parma, Italy)
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Cardinale, M. Corradi, R. Tesse, A. Manca, F. De Robertis, T. Tronci, A. Dellino, M. Berardi, M. F. Mastrototaro, M. S. Loffredo, F. Mangini, F. Cristofori, F. Di Domenico, L. Armenio (Bari, Parma, Italy). Exhaled oxidative stress biomarkers and its response to antibiotic treatment in cystic fibrosis (CF). Eur Respir J 2007; 30: Suppl. 51, 343
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Exhaled pentane – a new breath test in cystic fibrosis? Source: Annual Congress 2006 - New developments in infant and intensive care lung function Year: 2006
Exhaled 8-isoprostane, a marker of oxidative stress, is increased in patients with bronchiectasis Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation Source: Eur Respir J 2004; 24: Suppl. 48, 45s Year: 2004
Is NO2/X index useful for evaluation of oxidative stress in exhaled breath condensate in cystic fibrosis? Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
Breath condensate pH in the monitoring of airways inflammation and its response to antibiotic treatment in cystic fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 450s Year: 2007
The relationship between CT assessed lung damage, and inflammatory markers in exhaled breath condensate of cystic fibrosis patients Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
Parameters of oxidative stress in exhaled breath condensate are more pronounced in females then in males with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 728s Year: 2005
Noninvasive biomarkers of airway inflammation and oxidative stress in the exhaled breath of patients with bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 371s Year: 2003
Clinically relevant early functional and diagnostic markers of lung disease in children Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120 Year: 2006
Increased nitrotyrosine in exhaled breath condensate in cystic fibrosis Source: Eur Respir J 2001; 17: 1201-1207 Year: 2001
Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation Source: Eur Respir J 2004; 24: 1011-1017 Year: 2004
Effect of inhaled L-arginine on airway nitric oxide in cystic fibrosis patients Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005
The effect of inhaled steroids on bronchial hyperreactivity, oxidative status, clinical and inflammatory paramerters in patients with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis: the balance between treatment and side-effects Year: 2007
NO metabolites in exhaled breath condensate in cystic fibrosis patients: correlation with pulmonary function, nutritional status and systemic inflammation Source: Eur Respir J 2006; 28: Suppl. 50, 715s Year: 2006
Antibiotic treatment decreases exhaled nitric oxide levels in cystic fibrosis patients Source: Eur Respir J 2004; 24: Suppl. 48, 384s Year: 2004
Exhaled nitric oxide in stable adult cystic fibrosis patients, during exacerbation and following CFTR-modifying treatment Source: Eur Respir J, 53 (5) 1802259; 10.1183/13993003.02259-2018 Year: 2019
Oxidative stress evaluation in exhaled breath condensate (EBC) vs induced sputum (IS) in the assessment of lung diseases Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006
The effects of antioxidant therapy on lung clearance, pulmonary function test and oxidant stress in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 258s Year: 2002
Exhaled aldehydes as markers of disease in critically ill patients Source: Annual Congress 2007 - Acute lung injury and inflammation Year: 2007
Cytokine status and nitrosative stress indicators in patients with an exacerbation of COPD Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015